Contrast-induced nephropathy: update with special emphasis on patients with diabetes.
Contrast-induced nephropathy (CIN) continues to be a significant complication of the increasing use of iodinated contrast media. There have been few new insights into pathogenesis; despite multiple strategies aimed at prophylaxis, very few have proven efficacious. This article reviews our current knowledge regarding CIN, with emphasis on patients with diabetes.